The AI Read is on a break. The last edition was November 15, 2026. Everything here stays open to read.
The AI Read
← AI News

Illustration, AI-generated from the story text. Tap a panel to read the story through it.

Morning Brief · November 5th 2026

Isomorphic Labs is in talks for about $5 billion at about $50 billion, six months after raising $2.1 billion

Alphabet's drug discovery spinout is negotiating the round, Bloomberg reports, and terms could change. That is the top of the range Bloomberg described in October and far more money than May's $2.1 billion, led by Thrive Capital. How much of it is new capital and how much buys out existing holders is not reported. Isomorphic has no approved drug, so the price rests on what its models might do in trials. SourcesBB

Sources

This story ran in the Morning Brief of November 5th 2026.